TLDR Post-COVID conditions increase health care needs for six months after infection.
This study analyzed health care utilization in 127,859 patients with SARS-CoV-2 infection compared to an equal number of matched controls, revealing a 4% increase in health care use among those with positive results. Key post-COVID conditions included alopecia, bronchitis, pulmonary embolism, and dyspnea, with alopecia notably persisting up to 6 months. The study found an additional 213 health care visits per 1,000 patients, totaling over 27,200 excess visits, indicating a significant strain on health care resources. It emphasized the need for strategic health care planning to manage the long-term impacts of COVID-19, highlighting differences in post-COVID condition patterns between adults and children. Limitations included a 6-month follow-up period and potential underestimation of conditions due to survival bias.
1250 citations
,
August 2021 in “Scientific Reports” COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.
213 citations
,
December 2020 in “Annals of internal medicine” Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.
737 citations
,
August 2020 in “Journal of Infection” Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.
119 citations
,
May 2020 in “Journal of The American Academy of Dermatology” Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.
134 citations
,
April 2020 in “Journal of Cosmetic Dermatology” Male pattern hair loss could hint at androgens affecting COVID-19 severity.
August 2024 in “Journal of Dermatology for Physician Assistants” Early treatment of COVID-19-related hair loss is crucial for better outcomes.
COVID-19 may trigger or worsen rapid hair loss in alopecia areata.
71 citations
,
April 2020 in “Journal of Cosmetic Dermatology” Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.
April 2021 in “Libyan journal of medical sciences” A woman's hair loss improved with treatment after a COVID-19 infection.
4 citations
,
March 2022 in “Journal of Infection” Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.
123 citations
,
May 2020 in “Drug Development Research” Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.